Live Webinar: Advancing Drug Development with ICP-MS: A Bioanalytical Perspective

The pharmaceutical industry faces increasing pressure to develop complex therapeutics under ever tighter regulatory scrutiny.

Elemental impurities can halt programmes late in development, uncharacterised bioanalytical risks may undermine safety assessments, and advanced modalities like metallodrugs demand tools capable of providing reliable data at trace levels. Traditional LC–MS workflows, while powerful, cannot fully address these challenges. Failure to adopt the right analytical strategies early on risks costly delays, failed regulatory submissions, or missed opportunities in competitive pipelines.

In this webinar, we will demonstrate how Inductively Coupled Plasma Mass Spectrometry (ICP-MS) provides unmatched sensitivity and specificity for detecting and quantifying trace elements in complex biological matrices. You will gain insight into real case studies—ranging from pharmacokinetics of metal-based drugs, measurement of endogenous biomarkers, to speciation studies—that highlight how ICP-MS addresses key bioanalytical hurdles.

Don’t miss this opportunity to discover how ICP-MS can help you stay ahead of the analytical challenges shaping drug development. Register today to secure your place and learn how our expertise can help you bring innovative medicines to patients faster and with greater confidence.

Attendees will also learn how Arcinova integrates ICP-MS into end-to-end bioanalytical services.